Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
resTORbio reports interim data from Parkinson’s trial
Parkinson’s disease is a progressive neurodegenerative condition that affects nearly 7.5 million people globally. Credit: Sabine Zierer from Pixabay.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry
-
Viedoc Technologies
Viedoc Technologies offers a new way of looking at data...
About
Viedoc Technologies offers a new way of looking at data collection in clinical research. We design and create smart solutions and efficient applications for clinical trials in all therapeutic areas and phases.
FollowMake an Enquiry
-
OnAsset Intelligence
OnAsset’s SENTRY devices are widely used for real-time tracking and...
About
OnAsset’s SENTRY devices are widely used for real-time tracking and monitoring life sciences and pharmaceutical shipments around the globe.
Products
Hybrid Solutions
OnAsset offers enhanced, custom supply chain monitoring solutions to meet the specific challenges you face.
Enterprise API and Mobile Applications
We created our Enterprise API to deliver your data to you in a secure manner leveraging industry-standard methods and formats to make it easy.
FollowMake an Enquiry
